Cantel Medical's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Cantel Medical (CMD) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Cantel Medical vs Its Competitors
- TTM: Trailing 12-month revenue of 1,138M vs -M combined for its competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+10.3% annualized vs trailing 12 months).
- Peer revenue share: Cantel Medical accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
- Structure: Cantel Medical operates in the following segments: Medical, Dental, Life Sciences, Dialysis.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
CMD Sales vs. its Competitors, Q3 2021
Cantel Medical generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
API endpoints for this dataset
For context: the Medical Equipment & Supplies industry grew revenue 14.5% year over year, combined, vs 32.5% for Cantel Medical. Cantel Medical's share of combined industry revenue moved from 0.23% to 0.27%, a gain of 0.04 percentage points.
Cantel Medical's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Cantel Medical Corp | Yes | Yes | Yes | No |
| High-Confidence Competitors (14) | ||||
| Similar Growth & Profitability (8) | 100.00 % (8 of 8) | 100.00 % (8 of 8) | 75.00 % (6 of 8) | 0.00 % (0 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
CMD Stock Performance relative to its Competitors
CMD Stock Performance relative to High-Confidence Competitors
CMD Stock Performance relative to Similar Growth & Profitability Competitors
Cantel Medical's Competitors Named by the Company
Competitive relationships identified from Cantel Medical reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Motus Gi Holdings Inc | Company report | 85% |
| Tomi Environmental Solutions Inc | Company report | 85% |
| Integra Lifesciences Holdings Corp | Company report | 85% |
| Ecolab | Company report | 85% |
| Stryker | Company report | 85% |
| Belimed | Company report | 85% |
| Crothall | Company report | 85% |
| Olympus | Company report | 85% |
| Ruhof | Company report | 85% |
| Baxter | Company report | 85% |
| Fortive | Company report | 85% |
| Karl Storz | Company report | 85% |
| Skytron | Company report | 85% |
| BBraun | Company report | 85% |
| Contec | Company report | 85% |
| Getinge | Company report | 85% |
| Stilmas | Company report | 85% |
| Boston Scientific | Company report | 85% |
| Fedegari | Company report | 85% |
| Pentax | Company report | 85% |
| SteelCo | Company report | 85% |
| Wassenburg | Company report | 85% |
| Agiliti | Company report | 85% |
| Hill-Rom | Company report | 85% |
| CleanLease (Clean Lease Fortex) | Company report | 85% |
| Mobile | Company report | 85% |
| Rentex Awé | Company report | 85% |
| Sterilog Limited | Company report | 85% |
| Berendsen plc | Company report | 85% |
| Owens & Minor | Company report | 85% |
| Techniplast | Company report | 85% |
| Northfield | Company report | 85% |
| Rentex Floren | Company report | 85% |
| MECO | Company report | 85% |
| Solventum Corporation | Company report | 85% |
| Mesa Laboratories Inc | Company report | 85% |
| Conmed Corporation | Company report | 85% |
| Aptargroup inc | Company report | 85% |
| Danaher Corporation | Company report | 85% |
| Sotera Health Company | Company report | 85% |
| Thermo Fisher Scientific Inc | Company report | 85% |
Company report basis, confidence, active dates and source counts for Cantel Medical's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Cantel Medical's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Cantel Medical Corp | Medical 47.40 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).